Aquatic Capital Management LLC Makes New Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

Aquatic Capital Management LLC purchased a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 3,305 shares of the company’s stock, valued at approximately $69,000.

Other institutional investors have also recently bought and sold shares of the company. Quantbot Technologies LP raised its holdings in shares of Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock worth $107,000 after acquiring an additional 2,018 shares during the last quarter. Meeder Asset Management Inc. bought a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $113,000. New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after buying an additional 775 shares during the last quarter. Nebula Research & Development LLC bought a new stake in Phibro Animal Health during the fourth quarter worth $210,000. Finally, Amundi raised its position in Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after buying an additional 6,403 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on PAHC shares. Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Finally, Morgan Stanley set a $20.00 target price on Phibro Animal Health in a research note on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $19.75.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $19.53 on Tuesday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The firm has a market cap of $791.02 million, a price-to-earnings ratio of 40.69, a P/E/G ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a 52 week low of $16.06 and a 52 week high of $26.55. The firm’s 50-day simple moving average is $20.20 and its two-hundred day simple moving average is $21.92.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, equities analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.